Qiagen NV is a global leader in providing comprehensive solutions that convert biological materials into valuable molecular insights. Founded in 1986 and based in Venlo, the Netherlands, Qiagen serves a wide range of customers in molecular diagnostics, academia, pharmaceuticals, and applied testing. The company's offerings include a variety of consumables and instruments for nucleic acid purification, genotyping, gene expression analysis, and more. Qiagen also specializes in assays for a range of applications, from prenatal testing to infectious disease detection and forensic analysis, complemented by powerful bioinformatics solutions.